Advertisement

Rubidomycin pp 24-45 | Cite as

Biological Activity

  • J. Bernard
  • R. Paul
  • M. Boiron
  • Cl. Jacquillat
  • R. Maral
Part of the Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer book series (RECENTCANCER, volume 20)

Abstract

The choice of constituent A, i. e. rubidomycin, for use in chemotherapy [164, 165] was based on its greater stability, the fact that it could be obtained in the crystalline state [62] and, as found, in particular, with mice, its higher curative ratio; these factors more than outweighed its lower biological activity in absolute terms.

Keywords

Rous Sarcoma Virus Ehrlich Ascites Tumor Cytostatic Activity Lethal Damage Weight Inhibition 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag Berlin · Heidelberg 1969

Authors and Affiliations

  • J. Bernard
  • R. Paul
  • M. Boiron
  • Cl. Jacquillat
  • R. Maral

There are no affiliations available

Personalised recommendations